Agetech World https://validator.w3.org/feed/docs/rss2.html Unlocking the Healthcare AI Opportunity Pancreatic cancer drug could double survival rates, study suggests Loneliness does not accelerate dementia, study suggests Metabolic liver disease to affect almost 2bn by 2050 Live Forever series: Dr Clint Phillips ‘Gamechanger’ Alzheimer’s drugs have ‘no meaningful’ effect, review finds AI tool predicts heart failure five years before it develops Atrogi starts muscle-preserving drug trial NHS to review cost effectiveness of new Alzheimer’s drugs Diabetes patients face increased risk of undiagnosed heart failure Landmark prostate cancer screening trial begins in UK Osteoporosis drugs could reduce dementia risk, study suggests UK government announces £6.3m fund to boost men’s health Vitamin D may lower Alzheimer’s risk, study suggests Agetech world investment, research and technology round-up Daily Alzheimer’s pill slows brain shrinkage and improves cognition – study Live forever report part three: Dr Cherry Lo €1m Picasso painting to be won for €100 to support Alzheimer’s research Plant-rich diet linked to lower dementia risk, study finds Menstruation costs £20,359 a lifetime, sparking calls for Government action Social isolation is a horrible consequence of dementia – AI could be an answer Gut-friendly foods may damage heart, charity warns Centenarian study probes healthy ageing Astellas and Vir strike prostate cancer deal Brain health collaboratory launches in Gulf South Blood test could spot dementia years earlier Special report: Can humankind really live forever? Tool shows promise for improving mental health discharge for dementia patients Live Forever report part two: Dr Halland Chen Scientists identify top non-drug treatments for knee osteoarthritis Diabetes drug may echo benefits of exercise in prostate cancer care Agetech World finance & investment round-up Blood pressure readings could predict future dementia risk Phone-like device gives hope to dementia patients Alzheimer’s mutation may delay disease onset Aerska raises US$39m for brain RNA medicines Trial tests implant for stress urinary incontinence Working nights undermines type 2 diabetes management – study Active sitting linked to lower dementia risk Mentally active behaviour while sitting may reduce dementia risk Weight loss drugs to be offered to 1.2m people at risk of heart attacks and strokes Longevity startup Biopeak raises US$2.7m Harbor Health acquires dementia care startup Rippl French biotech raises €12m for osteoarthritis trial Cheap diabetes drug could slash prostate cancer risk Korsana raises US$175m for Alzheimer’s therapy Eye care startup raises €3.5m Gut health supplement relieves arthritis pain, research finds US$80m backs exceptional longevity study Home